Literature DB >> 24423899

Findings of cardiac magnetic resonance imaging in asymptomatic myocardial ischemic disease in Takayasu arteritis.

Cloé Comarmond1, Philippe Cluzel2, Dan Toledano2, Nathalie Costedoat-Chalumeau1, Richard Isnard3, Julien Gaudric4, Laurent Chiche4, Fabien Koskas4, Patrice Cacoub1, David Saadoun5.   

Abstract

Takayasu arteritis (TA) may affect myocardium and cause coronary stenosis. The aim of this study was to assess the prevalence and pattern of myocardial disease in patients with TA, using late gadolinium enhancement (LGE) of cardiac magnetic resonance imaging (CMRI). Twenty-seven consecutive patients with TA and 80 age- and gender-matched controls without known cardiovascular disease underwent CMRI. The prevalence of myocardial ischemic disease, as revealed by LGE, was compared between patients with TA and controls, and factors associated with myocardial disease were identified in patients with TA. Myocardial ischemic disease, as characterized by LGE on CMRI, was present in 7 (25.9%) of 27 patients with TA, and imaging with LGE showed a typical pattern of myocardial infarction in 6 patients (22.2%). Although both patients with TA and control subjects shared a similar risk of cardiovascular events, the prevalence of myocardial ischemia was >5× greater in patients with TA (p = 0.002 vs controls). No association was found between myocardial disease in patients with TA and cardiovascular atherosclerotic risk factors. The presence of myocardial scarring tended to be more closely associated with specific features of TA such as renovascular hypertension, older age at the onset of TA symptoms, male gender, aneurysmal dilatation, and Numano type V. In conclusion, finding of a significant and unexpectedly high prevalence of occult myocardial scarring in patients with TA indicates the usefulness of CMRI with LGE for the identification of occult myocardial disease in such patients.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24423899     DOI: 10.1016/j.amjcard.2013.11.045

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

Review 1.  Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk.

Authors:  Durga Prasanna Misra; Sajjan N Shenoy
Journal:  Rheumatol Int       Date:  2016-02-17       Impact factor: 2.631

Review 2.  Non-invasive imaging of vascular inflammation.

Authors:  Enrico Ammirati; Francesco Moroni; Patrizia Pedrotti; Isabella Scotti; Marco Magnoni; Enrica P Bozzolo; Ornella E Rimoldi; Paolo G Camici
Journal:  Front Immunol       Date:  2014-08-18       Impact factor: 7.561

Review 3.  [Cardiac manifestations of Takayasu's disease: observation and review of the literature].

Authors:  Abdelmajid Bouzerda; Ali Khatouri
Journal:  Pan Afr Med J       Date:  2016-05-25

4.  Multimodality assessment of left ventricular dysfunction in Takayasu arteritis and familial hypercholesterolaemia.

Authors:  Atsushi Okada; Hiroyuki Takahama; Masatsune Ogura; Yoshiaki Morita; Junichi Konma; Shuzo Yoshida; Shigeki Makino; Seiji Takashio; Makoto Amaki; Takahiro Ohara; Takuya Hasegawa; Yasuo Sugano; Hideaki Kanzaki; Mariko Harada-Shiba; Hatsue Ishibashi-Ueda; Satoshi Yasuda; Toshiaki Hanafusa; Toshihisa Anzai
Journal:  ESC Heart Fail       Date:  2017-07-31

5.  The clinical features of pulmonary artery involvement in Takayasu arteritis and its relationship with ischemic heart diseases and infection.

Authors:  Hiroki Mukoyama; Mirei Shirakashi; Nozomi Tanaka; Takeshi Iwasaki; Toshiki Nakajima; Hideo Onizawa; Hideaki Tsuji; Koji Kitagori; Shuji Akizuki; Ran Nakashima; Kosaku Murakami; Masao Tanaka; Akio Morinobu; Hajime Yoshifuji
Journal:  Arthritis Res Ther       Date:  2021-12-03       Impact factor: 5.156

6.  Association between Takayasu arteritis and ischemic heart disease: a cohort study.

Authors:  Mathilde Versini; Shmuel Tiosano; Kassem Sharif; Naim Mahroum; Abdulla Watad; Doron Comaneshter; Guy Shalom; Yehuda Shoenfeld; Arnon D Cohen; Howard Amital
Journal:  Mediterr J Rheumatol       Date:  2019-09-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.